GeneDx Holdings Corp. (WGS) stock
WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)
Close on Nov 16, 2026Market cap $1.52BP/E –Yield –
GeneDx total assets
Total assets on the balance sheet at the end of each period.
GeneDx's total assets was $481.49M at Jun 30, 2026. For fiscal 2025 it was $523.71M, up 24.9% from the year before. The highest annual figure on record is $554.09M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $523.71M | +24.9% |
| FY2024 | Dec 31, 2024 | $419.38M | +0.1% |
| FY2023 | Dec 31, 2023 | $418.76M | -14.7% |
| FY2022 | Dec 31, 2022 | $490.94M | -11.4% |
| FY2021 | Dec 31, 2021 | $554.09M | +120.2% |
| FY2020 | Dec 31, 2020 | $251.64M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $481.49M | +3.8% |
| Q1 FY2026 | Mar 31, 2026 | $506.30M | +13.4% |
| Q4 FY2025 | Dec 31, 2025 | $523.71M | +24.9% |
| Q3 FY2025 | Sep 30, 2025 | $493.90M | +20.8% |
| Q2 FY2025 | Jun 30, 2025 | $463.86M | +19.2% |
| Q1 FY2025 | Mar 31, 2025 | $446.43M | +13.2% |
| Q4 FY2024 | Dec 31, 2024 | $419.38M | +0.1% |
| Q3 FY2024 | Sep 30, 2024 | $408.84M | -2.0% |
| Q2 FY2024 | Jun 30, 2024 | $389.10M | -18.3% |
| Q1 FY2024 | Mar 31, 2024 | $394.53M | -27.6% |
| Q4 FY2023 | Dec 31, 2023 | $418.76M | -14.7% |
| Q3 FY2023 | Sep 30, 2023 | $417.29M | -49.7% |
| Q2 FY2023 | Jun 30, 2023 | $476.39M | -49.0% |
| Q1 FY2023 | Mar 31, 2023 | $545.30M | +5.3% |
| Q4 FY2022 | Dec 31, 2022 | $490.94M | -11.4% |
| Q3 FY2022 | Sep 30, 2022 | $828.97M | +37.4% |
| Q2 FY2022 | Jun 30, 2022 | $933.28M | +431.7% |
| Q1 FY2022 | Mar 31, 2022 | $517.67M | +136.1% |
| Q4 FY2021 | Dec 31, 2021 | $554.09M | +120.2% |
| Q3 FY2021 | Sep 30, 2021 | $603.36M | +35.8% |
| Q2 FY2021 | Jun 30, 2021 | $175.53M | – |
| Q1 FY2021 | Mar 31, 2021 | $219.30M | – |
| Q4 FY2020 | Dec 31, 2020 | $251.64M | – |
| Q3 FY2020 | Sep 30, 2020 | $444.22M | – |
See a number that looks wrong?